Incyte

Latest news

• Wells Fargo Adjusts Price Target on Incyte to $128 From $116, Keeps Equalweight Rating (opens in a new tab)

  marketscreener.com · Oct 1, 2026

• Incyte presents EADV data for Incyte stock (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• Incyte stock trades at EUR 110.18 after an Atebrioz target hike (opens in a new tab)

  AD HOC NEWS · Sep 29, 2026

• Incyte stock at USD 124.31 on September 28, 2026 (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment (opens in a new tab)

  Benzinga · Sep 28, 2026

• Mirum and Incyte gain approval of zilurgisertib for rare bone disorder (opens in a new tab)

  Seeking Alpha · Sep 26, 2026

• Incyte Stock Price Forecast. Should You Buy INCY? (opens in a new tab)

  StockInvest.us · Sep 25, 2026

• Incyte stock reports 38 percent revenue growth as shares trade at USD 123.47 (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• Form 4 Incyte Corporation For: 25 September By Investing.com (opens in a new tab)

  Investing.com UK · Sep 25, 2026

• Incyte stock heads into the open after a 1.23 percent drop (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• Incyte stock holds near its yearly high as RBC keeps target (opens in a new tab)

  AD HOC NEWS · Sep 23, 2026

• Incyte Expands Skin Diseases Treatment Partnership in Australia (opens in a new tab)

  marketscreener.com · Sep 21, 2026

• Incyte stock gains attention as Opzelura partnership in Australia expands (opens in a new tab)

  AD HOC NEWS · Sep 21, 2026

• What Is Incyte Corporation (NASDAQ:INCY) Signaling Through Its Pipeline? (opens in a new tab)

  Kalkine Media · Sep 18, 2026

• Incyte stock gains after Morgan Stanley conference highlights pipeline strategy (opens in a new tab)

  AD HOC NEWS · Sep 17, 2026

• Incyte stock heads into the open after a 0.4% slip (opens in a new tab)

  AD HOC NEWS · Sep 17, 2026

• Incyte: Priced For Success, With No Margin Of Safety (NASDAQ:INCY) (opens in a new tab)

  Seeking Alpha · Sep 15, 2026

• Incyte (INCY): 3 Reasons We Love This Stock (opens in a new tab)

  Yahoo Finance · Sep 14, 2026

• Incyte stock gains institutional support as shares trade near 52-week high (opens in a new tab)

  AD HOC NEWS · Sep 11, 2026

• Incyte: Solid Strategies For Continued Growth, But A Possible Pullback Looms (NASDAQ:INCY) (opens in a new tab)

  Seeking Alpha · Sep 8, 2026